Next Article in Journal
Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells
Previous Article in Journal
JNK, p38, ERK, and SGK1 Inhibitors in Cancer
Article Menu

Export Article

Open AccessFeature PaperArticle
Cancers 2018, 10(1), 2; doi:10.3390/cancers10010002

Protein Kinase A Distribution Differentiates Human Glioblastoma from Brain Tissue

1
Department of Molecular Medicine, University of Padova, Padova 35131, Italy
2
Biostructures and Biosystems National Institute, Rome 00136, Italy
3
Department of Neuroscience, University of Padova, Padova 35131, Italy
4
Department of Food and Drug, University of Parma, Parma 43121, Italy
*
Author to whom correspondence should be addressed.
Received: 30 November 2017 / Revised: 13 December 2017 / Accepted: 13 December 2017 / Published: 21 December 2017
View Full-Text   |   Download PDF [12633 KB, uploaded 21 December 2017]   |  

Abstract

Brain tumor glioblastoma has no clear molecular signature and there is no effective therapy. In rodents, the intracellular distribution of the cyclic AMP (cAMP)-dependent protein kinase (Protein kinase A, PKA) R2Alpha subunit was previously shown to differentiate tumor cells from healthy brain cells. Now, we aim to validate this observation in human tumors. The distribution of regulatory (R1 and R2) and catalytic subunits of PKA was examined via immunohistochemistry and Western blot in primary cell cultures and biopsies from 11 glioblastoma patients. Data were compared with information obtained from 17 other different tumor samples. The R1 subunit was clearly detectable only in some samples. The catalytic subunit was variably distributed in the different tumors. Similar to rodent tumors, all human glioblastoma specimens showed perinuclear R2 distribution in the Golgi area, while it was undetectable outside the tumor. To test the effect of targeting PKA as a therapeutic strategy, the intracellular cyclic AMP concentration was modulated with different agents in four human glioblastoma cell lines. A significant increase in cell death was detected after increasing cAMP levels or modulating PKA activity. These data raise the possibility of targeting the PKA intracellular pathway for the development of diagnostic and/or therapeutic tools for human glioblastoma. View Full-Text
Keywords: glioblastoma; cAMP; protein kinase A; diagnosis glioblastoma; cAMP; protein kinase A; diagnosis
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Mucignat-Caretta, C.; Denaro, L.; D’Avella, D.; Caretta, A. Protein Kinase A Distribution Differentiates Human Glioblastoma from Brain Tissue. Cancers 2018, 10, 2.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top